Balci N C, Semelka R C
Department of Radiology, Florence Nightingale Hospital, Istanbul, Turkey.
Eur J Radiol. 2001 May;38(2):105-12. doi: 10.1016/s0720-048x(01)00295-9.
This article presents imaging modalities in the diagnosis and staging of pancreatic ductal adenocarcinoma. Magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS) have the highest accuracy in detection of pancreatic cancer. MRI and EUS have similar accuracy in determining the local extent of pancreatic cancer. Angiography, computed tomography (CT) angiography and EUS are similarly accurate in evaluating peripancreatic vascular involvement. MRI is the superior method for detecting liver metastases and peritoneal implants of pancreatic ductal adenocarcinoma. Endoscopic retrograde cholangiopancreatography (ERCP) and magnetic resonance cholangiopancreatography (MRCP) are used to assess the biliary tract of patients with pancreatic cancer. Positron emission tomography (PET) is useful in distinguishing pancreatic cancer from focal pancreatic inflammation.
本文介绍了胰腺导管腺癌诊断和分期中的成像方式。磁共振成像(MRI)和内镜超声检查(EUS)在胰腺癌检测中具有最高的准确性。MRI和EUS在确定胰腺癌的局部范围方面具有相似的准确性。血管造影、计算机断层扫描(CT)血管造影和EUS在评估胰腺周围血管受累情况方面同样准确。MRI是检测胰腺导管腺癌肝转移和腹膜种植的 superior 方法。内镜逆行胰胆管造影(ERCP)和磁共振胰胆管造影(MRCP)用于评估胰腺癌患者的胆道。正电子发射断层扫描(PET)有助于区分胰腺癌和局灶性胰腺炎症。